ReviewPoultry science2026
Flavonoids as multi-target protective agents against aflatoxin B1 toxicity: mechanistic convergence and translational challenges.
Review in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aflatoxin B1 (AFB1) is the most widespread and toxic mycotoxin found in food and feed. It is both chemically and physically stable and shows resistance to degradation during processing. AFB1 can cause damage to multiple organs, including the liver, immune system, nervous system, kidneys, reproductive system, intestines, and genetic material. Therefore, the development of a safe and effective antidote is urgently needed. Flavonoids are a class of natural polyphenols widely found in fruits, vegetables, and herbs, which can mitigate AFB1-induced organ toxicity through various mechanisms. However, the precise molecular mechanisms responsible for their detoxifying actions have yet to be systematically characterized and fully elucidated. Therefore, this review systematically summarizes the protective effects of flavonoids (including flavones, flavonols, dihydroflavones, dihydroflavonols, isoflavones, flavanols, chalcones, and anthocyanins, among others) against AFB1-induced multi-organ toxicity. These flavonoids primarily exert their protective effects by targeting multiple key pathways, including activation of the Nrf2/ARE antioxidant system, inhibition of the NF-κB/NLRP3 inflammatory axis, regulation of the Bax/Bcl-2/Caspase-3 apoptotic cascade, suppression of ferroptosis via the GPX4/xCT/ACSL4 pathway, and modulation of the gut-liver/spleen axis. This review provides a mechanistic basis for the development of flavonoid-based AFB1 detoxification strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.